OTC — Ocumetics Technology Balance Sheet
0.000.00%
- CA$37.13m
- CA$37.34m
Annual balance sheet for Ocumetics Technology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.001 | 1.84 | 0.602 | 0.236 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.001 | 0.052 | 0.041 | 0.044 |
Prepaid Expenses | ||||
Total Current Assets | 0.001 | 1.92 | 0.673 | 0.311 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | — | — | — | 0.068 |
Net Intangible Assets | ||||
Other Long Term Assets | ||||
Total Assets | 0.583 | 2.65 | 1.37 | 1.04 |
Payable / Accrued | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.142 | 0.261 | 0.244 | 0.624 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.642 | 0.761 | 0.536 | 0.945 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | -0.059 | 1.89 | 0.837 | 0.091 |
Total Liabilities & Shareholders' Equity | 0.583 | 2.65 | 1.37 | 1.04 |
Total Common Shares Outstanding |